Content
Recruiting
Study overview
This pragmatic clinical trial compares the effectiveness, safety, and patient experience of IV ketamine and intranasal esketamine in adults with treatment-resistant depression.
What participants should know
- Compare IV ketamine with SPRAVATO® (esketamine)
- Assess symptom change after eight treatments
- Evaluate safety and tolerability
Study eligibility information
Detailed public inclusion and exclusion criteria are maintained on the official registry record. Review ClinicalTrials.gov for the current listing.
The study team reviews eligibility after screening. Contact the research team if you would like to ask about the next step.
View NCT06713616 on ClinicalTrials.gov